Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Otodolor** is an Austrian pharmacy-only, non-prescription homeopathic otic combination product supplied as ear drops. It contains homeopathic dilutions of *Capsicum annuum*, *Matricaria recutita*, *Pulsatilla pratensis*, *Acidum silicicum*, and *Acidum boricum* in a glycerol-ethanol vehicle. It is indicated for symptomatic decongestion and pain relief in disorders of the external auditory canal, including irritation, redness, and eczematous crusting. A completed prospective non-interventional study evaluated Otodolor and Otodolor forte for topical treatment of acute or chronic otitis externa. The approved use and claimed effects are based on homeopathic experience rather than an established target-specific pharmacologic mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Otodolor.